Essential Planning LLC. Acquires New Position in Henry Schein, Inc. (NASDAQ:HSIC)

Essential Planning LLC. acquired a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 13,000 shares of the company’s stock, valued at approximately $934,000.

Other institutional investors also recently bought and sold shares of the company. Clarkston Capital Partners LLC boosted its holdings in shares of Henry Schein by 5.4% during the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock valued at $101,900,000 after acquiring an additional 71,560 shares during the last quarter. Nuance Investments LLC lifted its stake in shares of Henry Schein by 22.3% in the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after purchasing an additional 414,748 shares during the period. Olstein Capital Management L.P. lifted its stake in shares of Henry Schein by 17.2% in the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock worth $7,543,000 after purchasing an additional 16,000 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of Henry Schein in the 3rd quarter worth approximately $515,000. Finally, Private Management Group Inc. lifted its stake in shares of Henry Schein by 5.7% in the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company’s stock worth $24,256,000 after purchasing an additional 18,882 shares during the period. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Trading Down 0.2 %

Henry Schein stock opened at $69.81 on Friday. The stock has a market cap of $8.67 billion, a P/E ratio of 28.73, a PEG ratio of 2.13 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.49. The firm’s 50 day moving average price is $74.78 and its 200-day moving average price is $72.62.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.66 EPS. On average, equities analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. Wells Fargo & Company assumed coverage on shares of Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price objective on the stock. UBS Group lowered their price objective on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 26th. Mizuho assumed coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price on the stock. Barrington Research restated an “outperform” rating and set a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. Finally, Jefferies Financial Group raised their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Henry Schein presently has an average rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.